Actinomycesin AMSIN, Defensin-like Bacteriocin

General Information


DRACP ID  DRACP04356

Peptide Name   Actinomycesin AMSIN, Defensin-like Bacteriocin

Sequence  GFGCPWNAYECDRHCVSKGYTGGNCRGKIRQTCHCY

Sequence Length  36

UniProt ID  E7N5J9 

PubChem CID  Not available

Origin  Bacteria

Type  Native peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  2RU0 

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C171H253N55O50S6

Absent amino acids  LM

Common amino acids  CG

Mass  469607

Pl  8.38

Basic residues  7

Acidic residues  2

Hydrophobic residues  5

Net charge  5

Boman Index  -7909

Hydrophobicity  -77.5

Aliphatic Index  21.67

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  10345

Absorbance 280nm  295.57

Polar residues  20

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 34927385

Title  Adaptively evolved human oral actinomyces-sourced defensins show therapeutic potential

Doi Not available

Year  2022

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  19007

DRACP is developed by Dr.Zheng's team.